Telix Pharmaceuticals (TLX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TLX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with ...August 25 at 4:30 AM | gurufocus.comWhy Telix shares could rocket 60%+August 22, 2025 | msn.comRosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLXAugust 22, 2025 | tmcnet.comTelix Pharmaceuticals Limited: Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growthAugust 21, 2025 | finanznachrichten.deFDA Waiting Room: For Aussie applicants, it’s (mainly) business as usualAugust 11, 2025 | msn.comDr Boreham’s Crucible: Telix has homework but remains dux of radioimaging classAugust 5, 2025 | msn.comWhy did the Telix share price just plunge 18%?August 5, 2025 | msn.comBell Potter says this growing ASX 200 stock can rise over 40%July 12, 2025 | msn.comTelix Pharmaceuticals (TLX) Announces That Gozellix® is Commercially AvailableJuly 10, 2025 | msn.comTelix Pharmaceuticals Limited (TLX) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.com11 Best Mid-cap Healthcare Stocks to Buy According to Hedge FundsJuly 9, 2025 | insidermonkey.comTelix Pharmaceuticals Ltd Ordinary Shares TLX - MorningstarJune 26, 2025 | morningstar.comMTelix shares push higher on investor day updateJune 11, 2025 | msn.comTelix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.June 11, 2025 | finance.yahoo.comTelix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer DetectionJune 4, 2025 | finance.yahoo.comTelix Manufacturing Solutions (TMS) Established in Yokohama, JapanJune 4, 2025 | finance.yahoo.comTelix to Host Investor Day in New York City on June 11, 2025May 23, 2025 | morningstar.comMTelix at ANZSNM Annual Scientific Meeting 2025May 20, 2025 | finance.yahoo.comA Note On Telix Pharmaceuticals Limited's (ASX:TLX) ROE and Debt To EquityMay 16, 2025 | finance.yahoo.comTelix Pharmaceuticals Limited: Telix's Illuccix PSMA-PET Imaging Agent Approved in the Czech RepublicMay 5, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Telix's Illuccix PSMA-PET Imaging Agent Approved in FranceApril 29, 2025 | finanznachrichten.deTelix setback in drug approval in US, amid Trump workforce cuts to FDAApril 28, 2025 | afr.comTelix Pharmaceuticals Ltd ADR (TLX)April 27, 2025 | investing.comTelix: A masterclass in what this game is all aboutApril 24, 2025 | msn.comHealth Check: Telix shares rocket after bullish quarterly sales updateApril 23, 2025 | msn.comThe ASX's hottest company has gone from zero revenue to $1.2 billion in 4 yearsApril 23, 2025 | msn.comTelix shares rocket 15% on stellar Q1 sales updateApril 23, 2025 | msn.comTelix Pharmaceuticals Limited: IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy CandidateApril 15, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved in SwedenApril 15, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Telix Appoints Paul Schaffer as Chief Technology OfficerApril 7, 2025 | finanznachrichten.deTelix begins trial for new soft tissue sarcoma therapyApril 3, 2025 | investing.comARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®April 1, 2025 | markets.businessinsider.comHealth Check: Opthea’s solvency in question after monumental phase III eye disease trial failureMarch 23, 2025 | msn.comTelix Pharmaceuticals Ltd Share Price (TLX.US)March 21, 2025 | lse.co.ukUp 113% in a year, guess which ASX 200 healthcare stock just scored another FDA winMarch 20, 2025 | msn.comFDA Approves New Prostate Cancer Imaging Agent Gozellix®March 20, 2025 | finance.yahoo.comTelix shares slip 11% from highs. Time to buy this high flying biotech?March 20, 2025 | msn.comIlluccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaMarch 18, 2025 | markets.businessinsider.comUp 136% in a year, why is this ASX 200 share slipping on Wednesday?March 11, 2025 | msn.comHealth Check: Telix ‘mini me’ Clarity moves to next phase of prostate cancer therapy trialMarch 4, 2025 | msn.comGuess which ASX 200 company co-founders just sold $118 million in sharesFebruary 27, 2025 | msn.comFDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority ReviewFebruary 26, 2025 | markets.businessinsider.comHEALTH CHECK: After an ‘extraordinary’ year, analysts reckon Telix has a lot more tiger in the tankFebruary 23, 2025 | msn.comTelix share price jumps 13% on FY24 profit surgeFebruary 20, 2025 | msn.comStar biotech Telix makes $1.2b revenue pledgeFebruary 20, 2025 | afr.comUp 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'February 12, 2025 | msn.comTelix Pharmaceuticals Limited: Illuccix Approved in the United KingdomFebruary 12, 2025 | finanznachrichten.de10 Best Long Term ASX Stocks to Buy NowFebruary 11, 2025 | insidermonkey.comTelix Pharmaceuticals Limited: Illuccix Approved in DenmarkFebruary 11, 2025 | finanznachrichten.deWhy Dropsuite, Monadelphous, Sigma, and Telix shares are storming higher todayJanuary 27, 2025 | fool.com.au Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLX Media Mentions By Week TLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLX News Sentiment▼0.540.72▲Average Medical News Sentiment TLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLX Articles This Week▼41▲TLX Articles Average Week Get the Latest News and Ratings for TLX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Oxford Nanopore Technologies News Genus News Biotest Aktiengesellschaft News Oxford Biomedica News PureTech Health News Faron Pharmaceuticals Oy News Fennec Pharmaceuticals News Avacta Group News Cybin News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:TLX) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access